title: Pharmacological and surgical treatments for obesity.
authors.affiliation: Duke University Medical Center, Durham, NC 27710, USA. dewal001@mc.duke.edu
authors.forename: Tracy
authors.initials: T
authors.lastname: DeWald
authors.forename: Lalita
authors.initials: L
authors.lastname: Khaodhiar
authors.forename: Mark P
authors.initials: MP
authors.lastname: Donahue
authors.forename: George
authors.initials: G
authors.lastname: Blackburn
mesh_terms: D019440:Anti-Obesity Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use; D050110:Bariatric Surgery; D002110:Caffeine / Q000494:pharmacology; D019587:Dietary Supplements; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004809:Ephedrine / Q000494:pharmacology; D054439:Ghrelin; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D036361:Peptide Hormones / Q000502:physiology; D018490:Serotonin Agents / Q000627:therapeutic use
chemical_list: D019440:Anti-Obesity Agents; D000924:Anticholesteremic Agents; D018687:Antidepressive Agents, Second-Generation; D001067:Appetite Depressants; D004791:Enzyme Inhibitors; D054439:Ghrelin; D007004:Hypoglycemic Agents; D036361:Peptide Hormones; D018490:Serotonin Agents; D002110:Caffeine; D004809:Ephedrine